Ibtissam Boukhriss

Ibtissam Boukhriss is a Clinical Trial Management Associate at Revolution Medicines since March 2024, with a background in clinical research and quality assurance. Previous roles include Clinical Research Associate at Telavant (acquired by Roche), Associate in Clinical Operations at Applied Molecular Transport, and Clinical QA Specialist I at Gilead Sciences. Ibtissam's expertise encompasses quality assurance, clinical change management, eTMF systems, and compliance with GMP, GCP, and GDP standards. Early career experience includes positions as a QA/QC Clinical Data Coordinator at Diablo Clinical Research and Clinical Trial Coordinator at Sylvester Comprehensive Cancer Center. Ibtissam holds a Master's degree in Journalism and Communication and a Bachelor's degree in Communication, along with a diploma in Broadcasting and Media Production.